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Abstract
Objectives To evaluate the accuracy of standard MRI,
diffusion-weighted MRI (DWI) and fusion images for the
diagnosis of locally recurrent rectal cancer in patients with a
clinical suspicion of recurrence.
Methods Forty-two patients with a clinical suspicion of
recurrence underwent 1.5-T MRI consisting of standard T2-
weighted FSE (3 planes) and an axial DWI (b0,500,1000).
Two readers (R1,R2) independently scored the likelihood of
recurrence; [1] on standard MRI, [2] on standard MRI+DWI,
and [3] on T2-weighted+DWI fusion images.
Results 19/42 patients had a local recurrence. R1 achieved an
area under the ROC-curve (AUC) of 0.99, sensitivity 100%
and specificity 83% on standard MRI versus 0.98, 100% and
91% after addition of DWI (p=0.78). For R2 these figures
were 0.87, 84% and 74% on standard MRI and 0.91, 89% and
83% with DWI (p=0.09). Fusion images did not significantly
improve the performance. Interobserver agreement was κ0.69
for standard MRI, κ0.82 for standard MRI+DWI and κ0.84
for the fusion images.
Conclusions MRI is accurate for the diagnosis of locally
recurrent rectal cancer in patients with a clinical suspicion
of recurrence. Addition of DWI does not significantly
improve its performance. However, with DWI specificity
and interobserver agreement increase. Fusion images do not
improve accuracy.
Keywords MRI . Diffusion magnetic resonance imaging .
Rectal neoplasms . Local neoplasm recurrence . Diagnosis
Introduction
Around 35% of colorectal cancer patients who undergo
curative surgical treatment will develop recurrent disease,
the majority of which occurring during the first 3 years after
surgery [1]. Relapse mainly occurs in the liver (20%) and
lungs (5–10%), while approximately 5–15% of patients will
develop a locoregional recurrence [2]. These local recur-
rences are associated with significant morbidity and
impaired quality of life. Whereas locally recurrent rectal
cancer has long been regarded as a rarely curable disease,
patients are now increasingly being considered for curative
salvage surgery, often combined with (neo)adjuvant chemo
and/or radiation treatment. The chances of cure after
resection are highest when all resection margins are
microscopically free of tumour [3]. To increase the chance
of cure it is therefore crucial to diagnose local recurrences
when still in an early stage. At present, it is not clear
whether imaging is beneficial during the surveillance of
patients after rectal cancer surgery and trials to establish the
role of imaging are ongoing [4–7]. If, however, during
surveillance a patient is suspected of a local recurrence
based on clinical symptoms and/or rising carcinoembryonic
antigen (CEA) levels, CT is the first investigation of choice
to confirm or rule out the presence of a local or distant
relapse [4, 7, 8]. A pelvic mass that enlarges on consecutive
postoperative CT studies is highly suspicious for a local
recurrence, although the diagnosis is not always easy to
make [9, 10]. Often the CT findings are equivocal and in
those cases 18F-Fluorodeoxygenase Positron Emission
Tomography (FDG-PET) or combined PET/CT have
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proven beneficial in identifying local tumour re-growth [10,
11]. False positive FDG-PET findings may, however, occur
in areas of postoperative inflammatory scar tissue, in the
case of displaced small bowel loops and because of the
proximity of the urinary bladder. Moreover, FDG-PET
lacks accuracy in the evaluation of a recurrence of the
mucinous tumour type and is less useful to evaluate tumour
resectability due to its insufficient spatial resolution [11,
12]. MRI on the other hand has proven valuable for
assessing the resectability of a diagnosed local recurrence
of rectal cancer [13], but its role in the detection of
recurrent tumour is not well established. The main
difficulty with MRI is the identification of a small growing
tumour in an area of fibrotic scar tissue [14–16]. Diffusion-
weighted MR imaging (DWI) is a promising technique for
the detection of small tumour volumes and its benefit has
also been shown in pelvic tumours [17–19]. The role of
DWI in the detection of locally recurrent rectal cancer has,
however, not been investigated yet. As an addition to
standard anatomical MRI, DWI could be useful to increase
the diagnostic performance for detection of locoregional
tumour recurrences [20]. Furthermore, previous studies
have suggested that image fusion of anatomical MRI and
DWI can contribute to a better detection of both primary
malignancies and recurrent disease, though again its role in
rectal cancer is not clear [20, 21].
The aim of this study therefore is to evaluate the
accuracy of standard pelvic MRI for the diagnosis of
locoregional tumour recurrence in patients with a clinical
suspicion of a recurrence after curative rectal cancer surgery
and to evaluate whether the addition of DWI and/or image
fusion of standard MRI and DWI improves its performance.
Materials and methods
Patients
This study retrospectively evaluated 42 consecutive patients
who underwent MR imaging for the evaluation of the
presence of a locally recurrent rectal cancer between June
2007 and April 2010. Because of the retrospective nature of
the study, informed consent was waived. The baseline
patient characteristics are given in Table 1. Twenty-six
patients were male and 16 were female. Median age was
66 years (range 22–87). All patients had previously
undergone curative-intent surgical treatment for primary
rectal cancer. Patients were referred for MRI when during
follow-up there was a clinical suspicion for a locoregional
tumour recurrence based on symptoms (pain, faecal blood
loss, changed bowel habits), clinical examination, increased
serum CEA and/or the presence of metachronous distant
tumour lesions. Eleven patients first underwent a CT
examination, before being referred for MRI. Nineteen
patients were diagnosed with a locally recurrent rectal
tumour, while in 23 patients no evidence of recurrence was
found. The locations of recurrence were as follows:
anastomotic (n=2), presacral (n=3), lateral pelvic nodes
(n=3), pelvic floor (n=3), local excision scar (n=5), rectal
lumen (n=1), peri-prostatic (n=1), and gluteus muscle (n=
1). The median time interval between surgical treatment of
the primary rectal tumour and the follow-up MRI for local
recurrence evaluation was 40 months (range 3–320).
Median follow-up between the MRI and present was
20 months (range 4–42).
MR imaging
Patients did not receive bowel preparation or spasmolytics.
MR imaging was performed at 1.5-T (Intera; Philips
Medical Systems, Best, The Netherlands). For signal
reception, a phased-array body coil was used. The standard
rectal MRI protocol consisted of 2D T2-weighted (T2W)
fast spin-echo (FSE) sequences in three planes; sagittal,
axial and coronal (TR/TE 8456/130 msec, 90° flip angle, 25
echotrain length, 6 NSA, 0.78×1.14×3.00 mm acquisition
voxel size, 30 slices, 6.03 min acquisition time). Since
2006, a DWI sequence had been implemented as part of the
standard rectal MRI protocol. The DWI sequence was an axial
diffusion-weighted sequence with background body signal
suppression (DWIBS [22], b-values 0,500,1000 s/mm2, TR/
TE 4829/70 msec, EPI factor 53, 4 NSA, 2.50×3.11×
5.00 mm acquisition voxel size, 50 slices, 10.37 min
acquisition time). The axial T2-weighted and DWI sequences
were obtained in identical planes. These were routinely angled
perpendicular to the rectal lumen. When no remaining rectal
lumen was present (after abdominoperineal or extended
resection) or in case of a pelvic mass located outside the
rectal lumen, the axial sequences were angled perpendicular to
the interface between the local area of suspicion and the
closest structure or organ. ADC maps including all three
b-values were automatically generated in greyscale at the
operating system.
Image fusion of T2-weighted MRI and DWI
MR images were exported in DICOM format and trans-
ferred to a Macintosh computer (iMac, Apple, Cupertino,
CA, USA). Fusion images of the axial T2-weighted and
b1000 diffusion-weighted images were generated using
OsiriX Medical Imaging Software, an open-source post-
processing software tool [23]. The field of view and slice
level of the diffusion images were automatically adjusted to
exactly match the T2-weighted MRI. The DWI images
were then converted to a red-to-yellow colour scale and
overlaid on the T2-weighted images.
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Image evaluation
The MR images were independently analysed by two
readers from an expert referral center: a pelvic MR expert
with 13 years expertise in reading MRI of rectal cancer
(RGHBT) and a junior GI radiologist with 3 years specific
expertise in pelvic MRI (VCC). The readers were aware of
the treatment, histological stage and tumour type of the
primary rectal cancer, but were blinded to each other’s
scoring results and to whether or not previous CT imaging
for the recurrence was present. They were also blinded to
the results from endoscopy, other imaging, surgery and
histopathology. This study design was chosen to reproduce
the clinical standard of practice, where radiologists are
exposed to a patient’s history of the primary tumour. Image
evaluation consisted of three separate reading protocols
conducted within the same reading session: (a) the
readers first evaluated the T2-weighted FSE images only
(further referred to as ‘standard MRI’), (b) immediately
thereafter the scoring was repeated after the b1000
diffusion images were added to the standard MRI (further
referred to as ‘standard MRI+DWI’). The low b-value
diffusion images and the ADC map were also at the
readers’ disposal. Finally (c) the fusion images of T2-
weighted MRI+DWI were assessed. Patients were eval-
uated in random order. The readers scored the likelihood
of a local tumour recurrence using a 5-point confidence
level scale (0=definitely absent, 1=probably absent, 2=
possibly absent/present, 3=probably present, 4=definitely
present). On T2-weighted MRI, focal areas showing a
mass effect, a signal intensity isointense to muscle and/or
a nodular or infiltrative border were considered highly
suspicious for tumour recurrence. On the high b-value
(b1000) DWI, focal areas of high signal intensity,
corresponding with possible tumour locations on standard
MRI were considered a criterion for tumour recurrence
(Fig. 1). On the fusion images focal areas of hyper-
intensity (yellow), corresponding with possible tumour on
T2-weighted MRI were considered suspicious for recur-
rent tumour. When a recurrent tumour was suspected, the
largest tumour diameter was measured on T2-weighted
MRI.
Table 1 Baseline characteristics of study patients
Variable No Patients
Recurrence (n=19) No Recurrence (n=23) Total (n=42)
Sex
Male 13 13 26
Female 6 10 16
Median age 68 (range 35–87) 64 (range 22–81) 66 (range 22–87)
Treatment of primary tumour
Surgery 6 3 9
5x5 Gy+surgery 2 5 7
Neoadjuvant and/or adjuvant chemoradiation+surgery 11 15 26
Type of primary surgery
Total mesorectal excision 14 22 36
Local excision (transanal endoscopic microsurgery) 5 1 6
Radicality of primary resection
R0 14 19 33
R1 3 4 7
R2 2 0 2
Synchronous metastases
Liver 5 4 9
Lung 1 1 2
Other 0 0 0
Metachronous metastases
Liver 4 4 8
Lung 5 5 10
Other 4 2 6
Median CEA at time of MRI (μg/l) 8 (range 1–2154) 3 (range 0,5–55) 4 (range 0,5–2154)
Previous recurrence 4 2 6
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Standard reference
The presence of a local recurrence (n=19) was histologi-
cally confirmed in 16 patients (surgical resection in 11 and
positive biopsy of the suspected tumour area in 5 patients).
In 3 patients the diagnosis of a local recurrence was made
based on concordant positive FDG-PET/CT findings (i.e.
positive FDG uptake at the exact location suspected for
tumour on MRI) as well as follow-up MRI and/or FDG-
PET/CT examinations. Furthermore, an inguinal lymph
node metastasis was confirmed by biopsy in 1 patient.
These 3 patients did not undergo surgical treatment of their
recurrence, because of unresectable disease. The absence of
a local recurrence (n=23) was confirmed by a combination
of the following: no abnormal findings on corresponding
FDG/PET-CT (n=8), no abnormal findings on colonoscopy
and/or negative biopsy results (n=4) and/or no signs of
tumour recurrence on consecutive imaging examinations
(CT, MRI and/or FDG-PET/CT) during a follow-up period
of at least 1 year (n=22). Median follow-up time for the
patients without recurrence was 23 months (range 14–41).
Statistical analysis
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS, version 16.0, Inc.,
Chicago, IL). Receiver operator characteristic (ROC) curve
analyses were performed to evaluate the diagnostic perfor-
mance for (a) standard MRI only, (b) standard MRI+DWI and
(c) fused T2-weighted+DWI images. Corresponding areas
under the ROC-curve (AUC), sensitivities, specificities, posi-
tive predictive values (PPV) and negative predictive values
(NPV) with 95% confidence intervals (CI) were calculated. For
these analyses it had been decided at the start of the study to
dichotomise the confidence level scores between 1 (probably
absent) and 2 (possibly absent/present). Differences in diag-
nostic performance between the 3 reading strategies were
analysed by comparing the ROC-curves according to the
method described by DeLong et al [24]. Weighted kappa-
values with quadratic kappa weighting (0.00–0.20 poor, 0.21–
0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good and 0.81–1.00
excellent interobserver agreement) were calculated to deter-
mine interobserver agreement between the two readers [25].
P-values <0.05 were considered statistically significant.
Results
Diagnostic predictive values including 95% confidence
intervals are provided in Table 2 for the three reading
methods. The ROC-curves are displayed in Fig. 2.
Standard MRI
When using only standard MRI, reader 1 achieved an AUC
of 0.99, sensitivity 100% and specificity 83%. For reader 2
these figures were 0.87, 84% and 74%.
Added value of DWI and fusion images
After addition of DWI, reader 1 achieved an AUC of 0.98,
sensitivity 100% and specificity 91%. Compared to
standard MRI (AUC 0.99), the difference in AUC was not
significant (p=0.78). For reader 2, AUC improved from
0.87 on standard MRI to 0.91 after addition of DWI (p=
0.09). He achieved a sensitivity of 89% and specificity of
83%. The added value of DWI is illustrated in Fig. 3, in
which a false positive finding on T2-weighted MRI was
corrected after addition of DWI. The addition of fusion
images did not improve the diagnostic performance as
compared to standard MRI+DWI (p=0.41 for reader 1 and
p=1.00 for reader 2).
Fig. 1 T2-weighted, b1000 diffusion-weighted and T2W+DWI fusion
images of a male patient with a local tumour recurrence situated in the
left gluteus muscle (arrows). On T2-weighted MRI (a), the signal of
the tumour is isointense compared to the muscles. On the DWI (b) and
fusion images (c) the tumour is visible as a lesion with high signal
intensity, compared to the suppressed signal of the surrounding
structures. Note the necrotic changes in the left internal obturator
muscle (arrowheads), resulting in slightly increased signal intensity on
the DWI and fusion images
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Interobserver agreement
Interobserver agreement for standard MRI was good (κ
0.69). After the addition of DWI, agreement was excellent
(κ 0.82). Agreement for the T2W+DWI fusion images was
excellent (κ 0.84).
Lesion size
In the 19 patients with recurrence, median lesion size
(largest tumour diameter) was 37 mm (range 13–81 mm).
Seven patients had a ‘small’ recurrence (<20 mm). Reader
1 detected all 7 small recurrences, both with standard MRI
and after addition of DWI. Reader 2 missed one small
recurrence on standard MRI, but detected all 7 after
addition of DWI (Fig. 4).
Eleven patients had undergone CT imaging before MRI.
In Table 3 and Fig. 5 the discrepancies between the CT
findings and MRI scorings are illustrated.
Discussion
The aim of this study was to assess the performance of MRI
for the diagnosis of locally recurrent rectal cancer in
patients with a clinical suspicion of a recurrence after rectal
cancer surgery and to evaluate whether the addition of
diffusion-weighted imaging and/or image fusion of stan-
dard MRI and DWI improves its performance.
Our results indicate that standard MRI on its own has a
high accuracy for the diagnosis of recurrent tumour in this
specific group of patients. The addition of DWI does not
significantly improve its performance. The high accuracy
using only standard MRI could partly be due to the
relatively high levels of expertise of the readers in this
study. Furthermore, some patients had relatively large
tumours, which were already correctly identified on
morphological MR imaging. The benefit of DWI might be
more pronounced for the detection of smaller tumours
Table 2 Diagnostic performance for identification of a local tumour recurrence
Parameter Reader 1 Reader 2
Standard MRI Standard MRI+DWI Fusion Standard MRI Standard MRI+DWI Fusion
Sensitivity 100 (19/19) 100 (19/19) 100 (19/19) 84 (16/19) 89 (17/19) 84 (16/19)
95% CI 88–100 89–100 89–100 68–94 75–97 69–93
Specificity 83 (19/23) 91 (21/23) 91 (21/23) 74 (17/23) 83 (19/23) 83 (19/23)
95% CI 73–83 82–91 82–91 61–82 70–89 70–90
PPV 83 (19/23) 90 (19/21) 90 (19/21) 71 (15/21) 80 (16/20) 79 (15/19)
95% CI 73–83 80–91 80–91 59–81 68–88 65–89
NPV 100 (19/19) 100 (21/21) 100 (21/21) 85 (17/20) 90 (19/21) 86 (19/22)
95% CI 88–100 90–100 90–100 70–94 77–97 73–94
Accuracy 90 (38/42) 95 (40/42) 95 (40/42) 79 (33/42) 86 (36/42) 83 (35/42)
95% CI 79–91 85–95 85–95 65–87 72–92 70–92
AUC 0.99 0.98 0.98 0.87 0.91 0.91
95% CI 0.96–1.00 0.94–1.00 0.93–1.00 0.75–0.98 0.82–1.00 0.82–1.00
PPV positive predictive value. NPV negative predictive value. AUC area under the ROC curve. 95% CI 95% confidence interval. Numbers are
percentages, absolute numbers are given in parentheses. Reader 1 is a senior GI radiologist with 13 years specific pelvic MR expertise. Reader 2 is
a junior GI radiologist with 3 years pelvic MR expertise.
Fig. 2 Receiver operator characteristics curves and areas under the
ROC-curve (AUC) for reader 1 (R1) and reader 2 (R2) for detection of
locally recurrent rectal cancer by using (1) standard MRI, (2) standard
MRI+DWI, and (3) T2-weighted MRI+DWI fusion images, respec-
tively. There were no significant differences in AUC between the three
reading designs for either of the two readers
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which are more difficult to detect within the fibrotic scar
tissue. Results from a recent study by Syk et al. showed that
mainly anastomotic recurrences—which tend to be smaller
in size—are missed with imaging, again suggesting that the
benefit from additional functional imaging may be higher in
the detection of these small tumours [26]. In our study we
indeed observed that DWI was helpful in such a case: the
less experienced radiologist detected one of the small
recurrences on MRI+DWI which he had overlooked before
(Fig. 4). Larger patient studies are, however, required to
further investigate and confirm the potential role of DWI in
small tumours.
Of interest was the fact that adding DWI improved the
interobserver agreement and reduced the number of false
positives. DWI thus seems to increase the confidence of
radiologists to rule out the presence of a recurrence (Fig. 3).
This a relevant finding, as it is known from previous studies
that standard MRI generally tends to overestimate the
presence of tumour within areas of fibrotic (postoperative)
scar tissue [14–16, 27]. De Lange et al. analysed the signal
intensities of areas suspected for local tumour recurrence on
T2-weighted MRI and reported equally low signal intensi-
ties for areas of desmoplastic reaction containing tumour
and areas of desmoplasia only [27]. It is especially in these
cases that the combination of the morphological informa-
tion from MRI and the functional information from DWI
can be beneficial in the diagnosis of recurrent tumour
growth. Fibrotic tissue typically has a low cellular density
and a large interstitial space, which results in low signal
intensity on high b-value (b1000) diffusion images.
Conversely, tumoural areas have a relatively high cellular
density, which will result in high signal on DWI [28]. Our
findings are in concordance with a previous report from
Nishie et al, who compared standard MRI to DWI and
fusion images for the diagnosis of pelvic tumour recur-
rences in a group of 28 patients with a variety of primary
Fig. 3 Axial T2-weighted, b1000 diffusion-weighted and T2W+DWI
fusion images of a male patient who had previously undergone a low
anterior resection. On T2-weighted MRI (a) there is an area of
intermediate signal intensity (arrows) that was erroneously interpreted
as a tumour recurrence by the first reader. On the DWI (b) and fusion
images (c), there is no focal high signal intensity in this area (circle)
and the reader adjusted his score. Follow-up imaging revealed no
tumour recurrence
Fig. 4 Axial T2-weighted, b1000 diffusion-weighted and T2W+DWI
fusion images of a male patient who had previously undergone
transanal endoscopic microsurgery. On T2-weighted MRI (a) there is a
small area of intermediate signal intensity (arrow), that was over-
looked by reader 2. On the DWI (b) and fusion images (c), there is a
clear focal area of high signal intensity and the reader now identified
the recurrence, which was later surgically removed and histologically
confirmed
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pelvic malignancies [20]. They found the fusion images of
T2-weighted MRI and DWI to perform the best with an
AUC of 0.95. The main gain from the addition of DWI was
the improved specificity from 47% on standard to MRI to
72% with DWI, indicating that false positivity could be
reduced by more than 20%.
As compared to the separate evaluation of the standard
MRI and diffusion images, the addition of image fusion did
not improve the performance of the readers in our study. Both
readers, however, experienced the fusion images to be helpful
for a better understanding of the anatomical correlation
between standard MRI and DWI. MRI is presently mainly
used as a pre-operative roadmap for surgeons to determine the
resectability of recurrence in patients who are potential
candidates for curative salvage surgery [14]. In this regard,
image fusion of standard MRI and DWI might be beneficial
and should be addressed by further studies.
In our study, 11 patients had undergone CT imaging
prior to MRI. In eight (73%) cases CT showed equivocal
findings and patients had to be referred for further imaging.
The readers were not aware of the fact that a CT had been
performed previous to the MRI, nor were any of the CT
findings revealed. In this study setting, all 8 patients were
correctly diagnosed by both readers, both on standard MRI
and on MRI plus DWI, suggesting that MRI has superior
sensitivity and specificity compared to CT. The limitation
of CT remains its inferior soft tissue contrast as compared
to MRI. Previous studies that have compared CT and MRI
for evaluation of local recurrences have reported similar
superiority of MRI, both for the detection of recurrent
tumour in this specific group of patients as well as for the
assessment of tumour resectability [29, 30]. In the current
study, MRI without contrast was used. Some authors have
suggested the use of dynamic contrast enhanced (DCE)
Patient No CT findings MRI (+ DWI) Outcome (Ref. standard)
R1 R2
2 – – – –
5 Inconclusive + + +
12 Inconclusive – – –
14 – – – –
18 Inconclusive + + +
26 Inconclusive – – –
30 Inconclusive – – –
33 + + + +
35 Inconclusive + + +
36 Inconclusive + + +
40 Inconclusive – – –
Table 3 Discrepancies between
CT findings and MRI
R1 reader 1, R2 reader 2.
+ indicates a local tumour
recurrence
- indicates no recurrence
Fig. 5 CT, T2-weighted and T2W+DWI fusion images of a male
patient who had previously undergone an abdominoperineal resection
for a distally located rectal tumour. On CT (a) there is a presacrally
located soft tissue mass. On CT it is not possible to discriminate
between postoperative scar tissue and recurrent tumour. On the
corresponding MRI (b) there is an area of hypointense signal intensity
indicating fibrosis (arrowheads). Located anterior to this fibrosis, there
is a bowel loop (*) This bowel loop was not opacified by the oral
contrast on CT, because it was located distally from the patient’s
ileostomy. On the fusion images (c) there are no areas of high signal
intensity, suggestive of recurrent tumour. Follow-up imaging revealed
no tumour recurrence
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Gadolinium sequences for a better diagnosis of recurrent
tumour [31, 32]. Results are, however, somewhat
conflicting as others have shown little improvement for
DCE compared to standard morphological MRI [33].
Our study is limited because of its retrospective nature.
Furthermore, we only observed a trend towards an
improved performance for MRI+DWI, which could partly
be due to the small sample size and the relatively high level
of experience of both readers in our study. The results of
our study are, however, promising and therefore warrant
further prospective studies to confirm the value of
MRI+DWI in larger patient groups and in a general clinical
setting.
In conclusion, this study shows that standard MRI on its
own has a high accuracy for the diagnosis of locally
recurrent rectal cancer. Addition of DWI does not signifi-
cantly improve its performance. However, addition of DWI
might help radiologists to more confidently rule out the
presence of a recurrence. Moreover, the use of DWI can
increase interobserver agreement. MRI is therefore promis-
ing as a tool to diagnose local recurrences after rectal
cancer surgery in the group of patients with a high clinical
suspicion for recurrence. Fusion images of MRI+DWI do
not further improve the diagnostic accuracy.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
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